Paid Clinical Trials in Stockton, CA
As of July 2026, 50 paid clinical trials are recruiting in Stockton, California. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Stockton offers studies at sites including Saint Joseph's Medical Center for conditions such as Breast Cancer, Melanoma, Stage IIIB Lung Cancer AJCC v8, Advanced Non-Small Cell Lung Cancer. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Stockton
Trials by drug in Stockton
Filter results
50 clinical trials
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
Use of fenoTRACK Device for Monitoring Changes of Fractional Exhaled Nitric Oxide (FeNO) in Uncontrolled Asthma Subjects and Controlled Asthma Subjects
A Real-world Chronic Myelogenous Leukemia (CML) Patient Disease Registry to Describe Patient Experience and Clinical Outcomes Among Patients With CML Receiving Approved First or Second Line Tyrosine Kinase Inhibitor (TKI) Therapy
Exactech Shoulder Post Market Clinical Follow-up Study
Getinge's Beating Heart Product Family Post-Market Clinical Follow-up (PMCF) Study
BostonGene and Exigent Genomic INsight Study
Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Family Communications After Genetic Testing
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Testing an Enhanced Digital Delivery Model for Inherited Cancer Genetic Testing in Young Adults With Cancer
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Mobile Health for Adherence in Breast Cancer Patients
Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Cancer
E-Mindfulness Approaches for Living After Breast Cancer
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations
Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Top Research Study Locations in Stockton
Researchers run research studies in Stockton, CA at 16 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Saint Joseph's Medical Center | Breast Carcinoma, Melanoma, RISS Stage I Plasma Cell Myeloma | 20 |
| Kaiser Permanente-Stockton | Breast Cancer, Lung Non-Small Cell Carcinoma, Ovarian Carcinoma | 17 |
| Manshadi Heart Institute | Cardiovascular Disease, Cardiovascular Disease and Lipoprotein(a), Heart Failure With Mildly Reduced Ejection Fraction | 3 |
| Stockton Hematology Oncology Medical Group | Breast Cancer, Breast Neoplasms, Carcinoma, Ductal, Breast | 3 |
| Alpine Orthopaedic Medical Group | Ankylosing Spondylitis, Fracture, Infections | 1 |
| Amb Surg Ctr of Stockton | Lumbar Spinal Stenosis | 1 |
| Bensch Clinical Research LLC | Asthma | 1 |
| Dameron Hospital | Lumbar Spinal Stenosis | 1 |
| GSK Investigational Site | Neoplasms, Head and Neck | 1 |
| St. Joseph's Medical Center | Heart Failure, Obesity | 1 |
| St. Joseph's Medical Center Stockton | Off Pump Coronary Artery Bypass Surgery | 1 |
| Stockton Hematology Oncology Group | Advanced Non-Small Cell Lung Cancer, Carcinoma, Non-Small-Cell Lung, Carcinoma, Non-Small-Cell Lung (NSCLC) | 1 |
| Stockton Hematology Oncology Medical Group (SHOMG) - Stockton (Suite B) | Advanced Non-Small Cell Lung Cancer, Metastatic Non-Small Cell Lung Cancer | 1 |
| Stockton Hematology Oncology Medical Group Inc | Chronic Myelogenous Leukemia - Chronic Phase | 1 |
| Stockton Surg Ctr | Lumbar Spinal Stenosis | 1 |
| University of the Pacific | Healthy Volunteers, Safety After Oral Intake | 1 |
Active & Upcoming Studies in Stockton (2026)
Recruiting trials in Stockton grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (36 active studies)
- Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations · Phase 3 · SWOG Cancer Research Network
- Family Communications After Genetic Testing · Alliance for Clinical Trials in Oncology
Cardiovascular (3 active studies)
- A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity · Phase 3 · Novo Nordisk A/S
- Getinge's Beating Heart Product Family Post-Market Clinical Follow-up (PMCF) Study · Maquet Cardiovascular
Diabetes & metabolic (2 active studies)
Mental health & behavior (1 active study)
- E-Mindfulness Approaches for Living After Breast Cancer · Phase 3 · NRG Oncology
Common conditions studied in Stockton
- Breast Cancer (3 active studies)
- Melanoma (3 active studies)
- Stage IIIB Lung Cancer AJCC v8 (3 active studies)
- Advanced Non-Small Cell Lung Cancer (2 active studies)
- Breast Carcinoma (2 active studies)
- Lung Non-Small Cell Carcinoma (2 active studies)
Leading research sponsors in Stockton
- Alliance for Clinical Trials in Oncology
- NRG Oncology
- SWOG Cancer Research Network
- ECOG-ACRIN Cancer Research Group
- Amgen
Frequently asked questions
How many paid clinical trials are currently recruiting in Stockton?
There are approximately 50 recruiting clinical trials in Stockton, California listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Stockton pay participants?
Most recruiting trials in Stockton compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Stockton?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Stockton?
The most common conditions under active study in Stockton include Breast Cancer (3), Melanoma (3), Stage IIIB Lung Cancer AJCC v8 (3), Advanced Non-Small Cell Lung Cancer (2), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Stockton?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Stockton on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Stockton?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Stockton?
Recruiting research sites in Stockton include Saint Joseph's Medical Center, Kaiser Permanente-Stockton, Manshadi Heart Institute, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Stockton right now?
The largest active categories in Stockton are Cancer & tumors (36), Cardiovascular (3), Diabetes & metabolic (2). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.